Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 9, 2012, Pages 1449-1462

  Wu, Huizhe ^a   Kang, Hui ^a   Liu, Yong ^a   Tong, Weiwei ^a   Liu, Duo ^a   Yang, Xiuli ^a   Lian, Minqiong ^a   Yao, Weifan ^a   Zhao, Haishan ^a   Huang, Desheng ^a   Sha, Xianzheng ^a   Wang, Enhua ^a   Wei, Minjie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

ABCB1; Anthracycline; Breast carcinoma; Genetic polymorphisms; Prognosis; Susceptibility

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; PROGESTERONE RECEPTOR; TAMOXIFEN;

ABCB1 GENE; ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FUNCTION; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEALTH STATUS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84866743952     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1209-z     Document Type: Article

References (39)

1. Ashariati A (2008) Polymorphism C3435T of the MDR-1 gene predict response to preoperative chemotherapy in locally advanced breast carcinoma with Her2/neu expression. Acta Medica Indonesiana 40(4):187-191
2. Balcerczak E (2010) ABCB1/ABCB1 gene polymorphisms as a prognostic factor in colorectal cancer. Int J Colorectal Dis 25(10):1167-1176
3. Balram C, Sharma A, Sivathasan C et al (2003) Frequency of C3435T single nucleotide ABCB1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates. Br J Clin Pharmacol 56(1):78-83
4. Cizmarikova M, Wagnerova M, Schonova L et al (2010) ABCB1 (C3435T) polymorphism: relation to the risk of breast carcinoma and therapeutic outcome. Pharmacogenomics J 10(1):62-69
5. Ferguson LR, De Flora S (2005) Multiple drug resistance, antimutagenesis and anticarcinogenesis. Mutat Res 591(1-2):24-33
6. Fossland VS, Stroop JB, Schwartz RC et al (2009) Genetic issues in patients with breast carcinoma. Surg Oncol Clin N Am 18(1):53-71
7. Fromm MF (2002) The in Xuence of MDR1 polymorphisms on p-glycoprotein expression and function in humans. Adv Drug Deliv Rev 54:1295-1310
8. Fung KL, Gottesman MM (2009) A synonymous polymorphism in a common ABCB1(ABCB1) haplotype shapes protein function. Biochim Biophys Acta 1794(5):860-871
9. George J, Dharanipragada K, Krishnamachari S et al (2009) A singlenucleotide polymorphism in the ABCB1 gene as a predictor of response to neoadjuvant chemotherapy in breast carcinoma. Clinical Breast carcinoma 9(3):161-165
10. Gervasini G, Carrillo JA, Garcia M et al (2006) Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer. Cancer 107(12):2850-2857
11. Goldstein DB, Cavalleri GL (2005) Genomics: understanding human diversity. Nature 437(7063):1241-1242
12. Goreva OB, Grishanova AY, Mukhin OV et al (2003) Possible prediction of the efficiency of chemotherapy in patients with lymphoproliferative diseases based on ABCB1 gene G2677T and C3435T polymorphisms. Bull Exp Biol Med 136(2):183-185
13. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nature reviews. Cancer 2(1):48-58
14. Gréen H, Söderkvist P, Rosenberg P et al (2006) mdr-1 Single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to Paclitaxel chemotherapy. Clin Cancer Res 12(3):854-859
15. Han JY, Lim HS, Yoo YK et al (2007) Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmaco-kinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer 110(1):138-147
16. Huang MY, Wang YH, Chen FM et al (2008) Multiple genetic polymorphisms of GSTP1 313AG, ABCB1 3435CC, and MTHFR 677CC highly correlated with early relapse of breast carcinoma patients in Taiwan. Ann Surg Oncol 15(3):872-880
17. Kafka A, Sauer G, Jaeger C et al (2003) Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast carcinoma. Int J Oncol 22(05):1117-1121
18. Kerb R (2006) Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett 234(1):4-33
19. Kimchi-Sarfaty C, Marple AH, Shinar S et al (2007a) Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics 8(1):29-39
20. Kimchi-Sarfaty C, Oh JM, Kim IW et al (2007b) A 'silent' polymorphism in the ABCB1 gene changes substrate specificity. Science 315(5811):525-528
21. Komar AA (2007) SNPs, silent but not invisible. Science 315:466-467
22. Kurzawski M, Drosdzik M, Suchy J et al (2005) Polymorphism in the P-glycoprotein drug transporter ABCB1 gene in colon cancer patients. Eur J Clin Pharmacol 61(5-6):389-394
23. Leonessa F, Clarke R (2003) ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 10:43-73
24. Leschziner GD, Andrew T, Pirmohamed M et al (2007) ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharmacogenomics J 7(3):154-179
25. Marsh S, McLeod HL (2007) Pharmacogenetics and oncology treatment for breast carcinoma. Expert Opin Pharmacother 8(2):119-127
26. Oselin K, Gerloff T, Mrozikiewicz PM et al (2003) ABCB1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes. Fundam Clin Pharmacol 17(4):463-469
27. Pan JH, Han JX, Wu JM et al (2009) ABCB1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-smallcell lung cancer. Respiration 78(1):49-55
28. Robert J, Morvan VL, Smith D et al (2005) Predicting drug response and toxicity based on gene polymorphisms. Crit Rev Oncol Hematol 54(3):171-196
29. Rodrigues FFO, Santos RE, Melo MB et al (2008) Correlation of polymorphism C3435T of the MDR-1 gene and the response of primary chemotherapy in women with locally advanced breast carcinoma. Genet Mol Res 7(1):177-183
30. Rybárová S, Hodorová I, Hajduková M et al (2006) Expression MDR proteins in breast carcinoma and its correlation with some clinical and pathological parameters. Neoplasma 53(2):128-135
31. Sheng X, Zhang L, Tong N et al (2012) MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies. Mol Biol Rep Feb 4 [Epub ahead of print]
32. Siegsmund M, Brinkmann U, Scháffeler E et al (2002) Association of the P-glycoprotein transporter ABCB1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 13(7):1847-1854
33. Sohn JW, Lee SY, Lee SJ, Kim EJ, Cha SI, Kim CH et al (2006) ABCB1 polymorphisms predict the response to etoposide cisplatin combination chemotherapy in small cell lung cancer. Jpn J Clin Oncol 36(3):137-141
34. Taheri M, Mahjoubi F, Omranipour R (2010) Effect of ABCB1 polymorphism on multidrug resistance expression in breast carcinoma patients. Genet Mol Res 9(1):34-40
35. Tatari F, Salek R, Mosaffa F et al (2009) Association of C3435T single-nucleotide polymorphism of ABCB1 gene with Breast carcinoma in an Iranian population. DNA Cell Biol 28(5):259-263
36. Turgut S, Yaren A, Kursunluoglu R et al (2007) ABCB1 C3435T polymorphism in patients with breast carcinoma. Arch Med Res 38(5):539-544
37. Wang D, Johnson AD, Papp AC et al (2005) Multidrug resistance polypeptide 1 (ABCB1, ABCB1) variant 3435C → T affects mRNA stability. Pharmacogenet Genomics 15(10):693-704
38. Wang J, Wang B, Bi J et al (2012) MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies. J Cancer Res Clin Oncol Feb 4 [Epub ahead of print]
39. Zhou SF (2008) Structure, function and regulation of p-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38(7-8):802-832